Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and nonarthritogenic) autoreactive T cell hybridoma clones

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3025-3033

  Buzás, Edit I ^a,b   Hanyecz, Anita ^a   Murad, Yanal ^a   Hudecz, Ferenc ^c   Rajnavölgyi, Eva ^d   Mikecz, Katalin ^a   Glant, Tibor T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; GLYCYLARGINYLVALYLARGINYLVALYLASPARAGINYLSERYLALANYLTYROSINE; INTERLEUKIN 5; PEPTIDE; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CELL CLONE; CYTOKINE PRODUCTION; FEMALE; HYBRIDOMA; IMMUNIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 0042333432     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3025     Document Type: Article

References (64)

1. Miltenburg, A. M. M., J. M. van Laar, R. de Kuiper, M. R. Daha, and F. C. Breedveld. 1992. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35:603.
2. Van der Graaff, W. L., A. P. A. Prins, B. A. C. Dijkmans, and R. A. W. van Lier. 1998. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 351:1931.
3. Kusaba, M., J. Honda, T. Fukuda, and K. Oizumi. 1998. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J. Rheumatol. 25:1466.
4. Poole, A. R., T. T. Glant, and K. Mikecz. 1988. Autoimmunity to cartilage collagen and proteoglycan and the development of chronic inflammatory arthritis. In The Control of Tissue Damage. A. M. Glaurer, ed. Elsevier Publishers (Biomedical Division), Amsterdam, pp. 55-65.
5. Glant, T. T., K. Mikecz, E. J. M. A. Thonar, and K. E. Kuettner. 1992. Immune responses to cartilage proteoglycans in inflammatory animal models and human diseases. In Cartilage Degradation: Basic and Clinical Aspects. J. F. Woessner and D. S. Howell, eds. Marcel Dekker. New York, pp. 435-473.
6. 1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum. 41:1019.
7. Klareskog, L., and H. McDevitt. 1999. Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions. Curr. Opin. Immunol. 11:657.
8. Rosenberg, L. C., and J. A. Buckwalter. 1986. Cartilage proteoglycans. In Articular Cartilage Biochemistry. K. E. Kuettner. R. Schleyerbach, and V. C. Hascall, eds. Raven Press, New York, pp. 39-57.
9. Glant, T. T., E. I. Buzás, A. Finnegan, G. Negroiu, G. Cs-Szabó, and K. Mikecz. 1998. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J. Immunol. 160:3812.
10. Glant, T. T., K. Mikecz, A. Arzoumanian, and A. R. Poole. 1987. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum. 30:201.
11. Mikecz, K., T. T. Glant, and A. R. Poole. 1987. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 30:306.
12. Glant, T. T., G. Cs-Szabó, H. Nagase, J. J. Jacobs, and K. Mikecz. 1998. Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage. Arthritis Rheum. 41:1007.
13. Buzás, E. I., F. R. Brennan, K. Mikecz, M. Garzó, G. Negroiu, K. Holló, G. Cs-Szabó, É. Pintye, and T. T. Glant. 1995. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol. 155:2679.
14. Mikecz, K., T. T. Glant, E. Buzás, and A. R. Poole. 1990. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 33:866.
15. + Th1 cells in a syngeneic system. J. Immunol. 168:6013.
16. Fassbender, H.-G. 1994. Inflammatory reactions in arthritis. In Immunopharmacology of Joints and Connective Tissue. M. E. Davies and J. T. Dingle, eds. Academic Press, London, pp. 165-198.
17. Buzás, E. I., A. Finnegan, K. Mikecz, G. Cs-Szabo, F. Hudecz, K. Uray, K. Hollo, and T. T. Glant. 1998. Discordant recognition of altered peptide ligands by two autoreactive murine T cell hybridoma clones specific to the same cartilage proteoglycan (aggrecan)-epitope. Arthritis Rheum. 41:S252.
18. Buzás, E. I., K. Mikecz, A. Finnegan, F. Hudecz, and T. T. Glant. 1999. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan (aggrecan) in arthritis. Arthritis Rheum. 42:S259.
19. Brennan, F. R., K. Mikecz, E. I. Buzás, D. Ragasa, G. Cs-Szabó, G. Negroiu, and T. T. Glant. 1995. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin. Exp. Immunol. 101:414.
20. Brennan, F. R., G. Negroiu, E. I. Buzás, C. Fülöp, K. Mikecz, and T. T. Glant. 1995. Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin. Exp. Immunol. 100:104.
21. Brennan, F. R., K. Mikecz, E. Buzás, and T. T. Glant. 1995. Interferon-γ but not granulocyte/macrophage colony-stimulating factor augments proteoglycan presentation by synovial cells and chondrocytes to an autopathogenic T cell hybridoma. Immunol. Lett. 45:87.
22. Krane, S. M., W. Conca, M. L. Stephenson, E. P. Amento, and M. B. Goldring. 1990. Mechanisms of matrix degradation in rheumatoid arthritis. Ann. NY Acad. Sci. 580:340.
23. Doege, K. J., M. Sasaki, T. Kimura, and Y. Yamada. 1991. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan: human-specific repeats, and additional alternatively spliced forms. J. Biol. Chem. 266:894.
24. Walcz, E., F. Deák, P. Erhardt, S. N. Coulter, C. Fülöp, P. Horváth, K. J. Doege, and T. T. Glant. 1994. Complete coding sequence, deduced primary structure, chromosomal localization and structural analysis of murine aggrecan. Genomics 22:364.
25. Hering, T. M., J. Kollar, and T. D. Huynh. 1997. Complete coding sequence of bovine aggrecan: comparative structural analysis. Arch. Biochem. Biophys. 345:259.
26. Moudgil, K. D., E. E. Sercarz, and I. S. Grewal. 1998. Modulation of the immunogenicity of antigenic determinants by their flanking residues, Immunol. Today 19:217.
27. Vacchio, M. S., J. A. Berzofsky, U. Krzych, J. A. Smith, R. J. Hodes, and A. Finnegan. 1989. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J. Immunol. 143:2814.
28. He, X., C. A. Janeway, Jr., M. Levine, E. Robinson, P. Preston-Hurlburt, C. Viret. and K. Bottomly. 2002. Dual receptor T cells extend the immune repertoire for foreign antigens. Nat. Immun. 3:127.
29. Littlewood, A. J., J. Russell, G. R. Harvey, D. E. Hughes, R. G. G. Russel, and M. Gowen. 1991. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129:1513.
30. Vignali, D. A., and J. L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179:1945.
31. + T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169:739.
32. Sette, A., S. Buus, E. Appella, J. A. Smith, R. Chesnut, C. Miles, S. M. Colon, and H. M. Grey. 1989. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. USA 86:3296.
33. Bartnes, K., F. Leon, J. P. Briand, and P. J. Travers. 1997. A novel first primary anchor extends the MHC class II I-Ad binding motif to encompass nine amino acids. Int. Immunol. 9:1185.
34. Reizes, B., M. Eisenstein, F. Mor, and I. R. Cohen. 1998. The peptide-binding strategy of the MHC class II I-A molecules. Immunol. Today 19:212.
35. Ohshima, S., Y. Saeki, T. Mima, M. Sasai, K. Nishioka, S. Nomura, M. Kopf, Y. Katada, T. Tanaka, M. Suemura, and T. Kishimoto. 1998. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95:8222.
36. Sasai, M., Y. Saeki, S. Ohshima, K. Nishioka, T. Mima, T. Tanaka, Y. Katada, K. Yoshizaki, M. Suemura, and T. Kishimoto. 1999. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 42:1635.
37. Flannery, C. R., C. B. Little, C. E. Hughes, C. L. Curtis, B. Caterson, and S. A. Jones. 2000. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biol. 19:549.
38. Wilkinson, K. A., M. H. Vordermeier, J. Kajtar, S. Jurcevic, R. Wilkinson, J. Ivanyi, and F. Hudecz. 1997. Modulation of peptide specific T cell responses by non-native flanking regions. Mol. Immunol. 34:1237.
39. Wucherpfennig, K. W., and J. L. Strominger. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597.
40. Kersh, G. J., and P. M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 380:495.
41. Mason, D. 1998. A very high level of crossreactivity is essential feature of the T-cell receptor. Immunol. Today 19:395.
42. Kersh, G. J., and P. M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259.
43. Quaratino, S., M. Feldmann, C. M. Dayan, O. Acuto, and M. Londei. 1996. Human self-reactive T cell clones expressing identical T cell receptor β chains differ in their ability to recognize a cryptic self-epitope. J. Exp. Med. 183:349.
44. Garcia, K. C., M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, and I. A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166.
45. Garboczi, D. N., and W. E. Biddison. 1999. Shapes of MHC restriction. Immunity 10:1.
46. Dittel, B. N., and C. A. Janeway, Jr. 2000. Differential sensitivity to mutations in a single peptide by two TCRs having identical β-chains and closely related α-chains. J. Immunol. 165:6334.
47. Los, M., M. van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. A. Baeuerle, W. Droge, P. H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81.
48. Hiemstra, H. S., P. A. van Veelen, S. J. M. Willemen, W. E. Benckhuijsen, A. Geluk, R. R. P. de Vries, B. O. Roep, and J. W. Drijthout. 1999. Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases. Eur. J. Immunol. 29:2385.
49. Hausmann, S., and K. W. Wucherpfennig. 1997. Activation of autoreactive T cells by peptides from human pathogens. Curr. Opin. Immunol. 9:831.
50. Melchers, I., J. Jooss-Rudiger, and H. H. Peter. 1997. Reactivity patterns of synovial T-cell lines derived from a patient with rheumatoid arthritis. 1. Reactions with defined antigens and auto-antigens suggest the existence of multireactive T-cell clones. Scand. J. Immunol. 46:187.
51. Gran, B., B. Hemmer, M. Vergelli, H. F. McFarland, and R. Martin. 1999. Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann. Neurol. 45:559.
52. Shi, Y., A. Kaliyaperumal, L. Lu, S. Southwood, A. Sette, M. A. Michaels, and S. K. Datta. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor α chain. J. Exp. Med. 187:367.
53. Schaeffer, E. B., A. Sette, D. L. Johnson, M. C. Bekoff, J. A. Smith, H. M. Grey, and S. Buus. 1989. Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. Proc. Natl. Acad. Sci. USA 86:4649.
54. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
55. Moudgil, K. D., S. Southwood, A. Ametani, K. Kim, A. Sette, and E. E. Sercarz. 1999. The self-directed T cell repertoire against mouse lysozyme reflects the influence of the hierarchy of its own determinants and can be engaged by a foreign lysozyme. J. Immunol. 163:4232.
56. Margulies, D. H. 1997. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models. Curr. Opin. Immunol. 9:390.
57. Sparbier, K., and T. Walden. 1999. T cell receptor specificity and mimoptopes. Curr. Opin. Immunol. 11:214.
58. Sercarz, E. E. 2002. Processing creates the self. Nat. Immun. 3:110.
59. + T cells. J. Exp. Med. 197:643.
60. Pober, J. S., M. S. Kluger, and J. S. Schechner. 2001. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann. NY Acad. Sci. 941:12.
61. Greening, J. E., T. I. Tree, K. T. Kotowicz, A. G. van Halteren, B. O. Roep, N. J. Klein, and M. Peakman. 2003. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells. Diabetes 52:717.
62. Zhang, J., K. Mikecz, T. T. Glant, and A. Finnegan. 2000. Spontaneous thymocyte apoptosis is regulated by mitochondrion-mediated signaling pathway. J. Immunol. 165:2970.
63. Blass, S. L., E. Puré, and C. A. Hunter. 2001. A role for CD44 in the production of IFN-γ and immunopathology during infection with Toxoplasma gondii. J. Immunol. 166:5726.
64. Iqbal, N., J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver. 2002. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J. Exp. Med. 195:71.